Drug Market Disruption

The current landscape of GLP-1 drugs reveals a disparity in access, primarily benefiting affluent individuals seeking minor weight loss. As prices need to decrease through competition, there's potential for these medications to address broader behavioral issues, such as addiction. Meanwhile, the NFT market faces skepticism, with many questioning its long-term viability and value.